Takeda Pharmaceutical Co. expects to book about ¥150 billion ($945 million) in restructuring charges for the fiscal year starting next month Japan’s largest drugmaker overhauls its business to cut cos...
Takeda Pharmaceutical Co. expects to book about ¥150 billion ($945 million) in restructuring charges for the fiscal year starting next month Japan’s largest drugmaker overhauls its business to cut cos...